Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.64 - $3.11 $12,352 - $23,424
-7,532 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$2.6 - $3.3 $5,691 - $7,223
-2,189 Reduced 22.52%
7,532 $22,000
Q4 2021

Feb 15, 2022

BUY
$3.05 - $7.08 $405 - $941
133 Added 1.39%
9,721 $30,000
Q3 2021

Nov 15, 2021

SELL
$6.68 - $15.26 $155,577 - $355,405
-23,290 Reduced 70.84%
9,588 $65,000
Q2 2021

Aug 16, 2021

BUY
$7.19 - $18.96 $236,392 - $623,366
32,878 New
32,878 $510,000

Others Institutions Holding GTBP

About GT Biopharma, Inc.


  • Ticker GTBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,557,700
  • Market Cap $96.4M
  • Description
  • GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...
More about GTBP
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.